ライフサイエンスコーパス: ephedrine

1 ioselective separation of metamphetamine and ephedrine.

2 nterest for ITMS analysis: o-nitrophenol and ephedrine.

3 times worsened, and where tried responded to ephedrine.

4 as increased when nicotine was combined with ephedrine.

5 iated by GABAB receptors were reduced 28% by ephedrine.

6 atecholamines were measured before and after ephedrine.

7 = albuterol > salmeterol > dobutamine > or = ephedrine.

8 albuterol, 2.5% for dobutamine, and 1.1% for ephedrine.

9 ine >/= fenoterol > albuterol > dobutamine > ephedrine.

10 weight, n = 9), or a mixture of nicotine and ephedrine (0.8 mg/kg of body weight and 5 mg/kg of body

11 of fraction of receptors lost/h) 0.082 with ephedrine, 0.250 with dobutamine, 0.148 with albuterol,

12 Ephedrine (100-1000 microM) slowed spontaneous firing an

13 Caffeine (10 mg/kg of body weight, n = 4), ephedrine (5 mg/kg of body weight, n = 4), nicotine (0.8

14 +/- 0.82) was not appreciably different from ephedrine (5.0 +/- 0.96) and significantly less than tha

15 rug treatment period, the monkeys were given ephedrine (6 mg) and caffeine (50 mg) orally three times

16 For example, herbal preparations may contain ephedrine (a drug), which might alter heart rate so that

17 All plasma catecholamines increased after ephedrine administration.

18 Technology (NIST) with certified values for ephedrine alkaloids, synephrine, caffeine, and selected

19 The use of salbutamol and ephedrine alone or combined with pyridostigmine or 3,4-D

20 h control rats; more than either nicotine or ephedrine alone.

21 mediated by a postsynaptic mechanism because ephedrine also reduced baclofen-induced hyperpolarizatio

22 ction: see text] Very practical synthesis of ephedrine analogues in high yields and enantiopurity was

23 S)-2 with biologically active amines (1R,2S)-ephedrine and (S)-dapoxetine were also investigated by (

24 The administration of ephedrine and caffeine (E+C) has been proposed to promot

25 ls comparing placebo with ephedrine (n = 5), ephedrine and caffeine (n = 12), ephedra (n = 1), and ep

26 Use of ephedra or ephedrine and caffeine is associated with increased risk

27 Ephedrine and ephedra promote modest short-term weight l

28 delta(2)H values were distinct from those of ephedrine and methylamphetamine samples of a semi-synthe

29 Increasing concentrations of ephedrine and pseudoephedrine also increased the number

30 Ephedrine and pseudoephedrine are stimulant drugs whose

31 strial routes used to produce the precursors ephedrine and pseudoephedrine by measurement of stable i

32 moselectivity for simultaneous separation of ephedrine and pseudoephedrine containing multiple chiral

33 termediate formation via the chlorination of ephedrine and pseudoephedrine enantiomers.

34 The channel blocking effects of ephedrine and pseudoephedrine might reduce the synaptic

35 ne, methamphetamine, MDMA, MDA), ephedrines (ephedrine and pseudoephedrine), antidepressant venlafaxi

36 ing 100 microM (D,L)-arginine, 10 microM (-)-ephedrine, and 10 microM lomefloxacin.

37 eutical compounds include DOPA, amphetamine, ephedrine, and penicillamine.

38 Mahuang, ephedrine, and related alkaloids have not benefited phys

39 hat biologically relevant central effects of ephedrine are more likely to be mediated either by non-d

40 excess (>95% ee in most cases) by way of an ephedrine-based oxazaphospholidine borane complex.

41 gest that patients should avoid nicotine and ephedrine before undergoing (18)F-FDG PET to minimize (1

42 By preparation of 30 samples of ephedrine by the "fully synthetic" industrial process an

43 Ephedrine can significantly facilitate the initial stage

44 in, whereas the weak agonists dobutamine and ephedrine caused only 3-4-fold increases, similar to lev

45 Taken together, these results suggest that ephedrine causes hyperpolarization and suppresses GABAB

46 ased (7.9-fold for nicotine and 3.7-fold for ephedrine), compared to the control rats.

47 Herbal ecstasy refers to ephedrine-containing preparations.

48 The only exceptions are E. sinica- and ephedrine-containing supplements, which have been associ

49 There is no regulation of the ephedrine content of available herbal ecstasy products.

50 The ephedrine derived imidazolidin-2-one 21 was allowed to r

51 However, ephedrine did not reduce fast synaptic potentials mediat

52 d as a function of coupling efficiency, with ephedrine, dobutamine, albuterol, fenoterol, and epineph

53 ctivation of the sympathetic nervous system, ephedrine does not stimulate BAT in humans.

54 tive phase permits isolating >50% of the (+)-ephedrine enantiomer as target compound in only 4 min.

55 e (amphetamine, methamphetamine, MDMA, MDA), ephedrines (ephedrine and pseudoephedrine), antidepressa

56 xyglucose PET-CT in every volunteer, whereas ephedrine failed to stimulate BAT.

57 ubs, including methylenedioxymethamfetamine, ephedrine, gamma-hydroxybutyrate; gamma-butyrolactone, 1

58 clear explanation for a beneficial effect of ephedrine in endplate diseases.

59 The combination of nicotine and ephedrine increased the uptake 12.0-fold, compared with

60 Ephedrine increases ischemia-dependent arrhythmias at do

61 othesis that the sympathomimetic activity of ephedrine increases the risk of lethal arrhythmias.

62 Fetal genotype may increase resistance to ephedrine-induced acidosis.

63 Both ephedrine-induced hyperpolarization and inhibition of ba

64 Although ephedrine is a centrally active stimulant, its effect on

65 The sympathomimetic amine, ephedrine, is used to augment physical performance and a

66 ed results for trials comparing placebo with ephedrine (n = 5), ephedrine and caffeine (n = 12), ephe

67 To assess the effects of ephedrine on cardiac autonomic control, baroreceptor ref

68 To study the effect of ephedrine on dopamine-containing cells, current-clamp mi

69 trials of efficacy and safety of ephedra and ephedrine on weight loss or athletic performance; disagr

70 n 24 hours prior to an adverse event or that ephedrine or an associated product was found in blood or

71 chloride were synthesized from either from l-ephedrine or d-pseudoephedrine hydrochloride in reaction

72 is of methylamphetamine hydrochloride from l-ephedrine or d-pseudoephedrine hydrochloride via reducti

73 etamine is often prepared from the precursor ephedrine or pseudoephedrine, which in turn are obtained

74 This analysis suggests that (1) ephedrine or salbutamol is the first choice of treatment

75 The magnitude of treatment effect with ephedrine or salbutamol seems to increase gradually, pea

76 se inhibitor, 65 of 69 patients who received ephedrine or salbutamol, 18 of 29 who were given 3,4-dia

77 ts/min no drug vs. 218 +/- 26 beats/min with ephedrine, p = 0.03).

78 Resolution of fluoroiodoacetic acid with ephedrine provides either enantiomeric form of the elect

79 plexes of seven model drugs (atenolol, DOPA, ephedrine, pseudoephedrine, isoproterenol, norepinephrin

80 al myasthenic syndromes respond favorably to ephedrine, pseudoephedrine, or albuterol.

81 We have shown here that chlorination of the ephedrine/pseudoephedrine compounds occurs via inversion

82 the aim of linking the intermediates to the ephedrine/pseudoephedrine starting materials.

83 olunteers, we found that the sympathomimetic ephedrine raised blood pressure, heart rate, and energy

84 Conversion of ten ephedrine samples to methylamphetamine showed that this

85 Ephedrine significantly (P<.01) increased vaginal pulse

86 Ephedra and ephedrine sometimes are used for weight loss or enhanced

87 The use of ephedrine-substituted quaternary ammonium binaphthyl sal

88 measured following administration of either ephedrine sulfate (50 mg) or placebo in a randomized, do

89 irst empirical examination of the effects of ephedrine sulfate, an alpha- and beta-adrenergic agonist

90 In the rats injected with nicotine or ephedrine, the mean uptake of (18)F-FDG, in percentage i

91 Despite perfusion with AMPT, the ability of ephedrine to cause hyperpolarization was restored after

92 her after 30 s of myocardial ischemia during ephedrine treatment (204 +/- 25 beats/min no drug vs. 21

93 had increased ventricular arrhythmias during ephedrine treatment (p = 0.01) and four had VF.

94 ve animals with increased arrhythmias during ephedrine treatment had none during a third exercise and

95 infarction were retested after five days of ephedrine use (Xenadrine, 0.4 mg/kg/day orally).

96 studies were controlled trials of ephedra or ephedrine used for weight loss or athletic performance a

97 ible case reports documented that ephedra or ephedrine was consumed within 24 hours prior to an adver

98 Ephedrine was helpful in half of the patients.

99 athletic performance were found; 7 trials of ephedrine were too heterogeneous to synthesize.